Repeat Performance In Aveo Pharmaceuticals After Spike In Price

em>Joel Elconin is the co-host of Benzinga's #PreMarket Prep, a daily trading idea radio show.

Aveo Pharmaceuticals Inc. AVEO shares are trading higher by $0.61 at $1.78 in Monday's session. The issue has retreated over $1.20 from its premarket high ($2.97) and $0.80 from its intraday high of $2.55. What sparked the rally was the announcement of a licensing deal with Novartis, in which the company will receive an upfront $15M payment as well as up to $311 in milestone payments. Today's trading action certainly resembles the price action in the issue on May 21. On that day the issue spiked to $3.50 following the results of TIVO-1 study for renal cell carcinoma. However, it turned out to be a "sell the news scenario as the issue retreated from the highs to close at $2.23. Over the next three months it drifted lower and make a new low for the recent slide on at $1.14 and ended the day $1.17. After flirting with the $3 level in the premarket trading. the issue managed a higher open at $2.47, but the rally lasted only another $0.08 to $2.55. From that level, it has continued to make new lows for the session and may not even end the session over.$2.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: TechnicalsIntraday UpdateMoversTrading IdeasPremarket outlook
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!